Loxo Oncology, Inc. (LOXO) stock prices updated...
 

Loxo Oncology, Inc. stock price

Loxo Oncology, Inc. latest news:


  • 11/14/2017 05:48:29

    Loxo, Bayer to co-develop cancer drugs in up to $1.55 bln deal

    Loxo Oncology Inc(LOXO) will collaborate with Germany's Bayer AG to develop and commercialize two of its cancer therapies, the companies said on Tuesday, in deal that could bring the U.S. drug developer up to $1.55 billion. The drugs - larotrectinib and follow-on compound LOXO-195 - are TRK inhibitors, which directly target an acquired rather than inherited genetic defect.

  • More trends:

    Lpath, Inc.LPTN | LPL Financial Holdings Inc.LPLA | LRAD CorporationLRAD | LSI Industries Inc.LYTS | lululemon athletica inc.LULU | Lumenis Ltd.LMNS | Lumentum Holdings Inc.LITE | Luminex CorporationLMNX | Lumos Networks Corp.LMOS | Luna Innovations IncorporatedLUNA |